Recently Published Articles on Vitiligo

Below you will find a list of recently published articles on vitiligo, subdivided into Review Articles, Clinical Articles, and Basic Science Articles. Each article is linked to its listing in PubMed. Please note that, due to copyright restrictions, the National Vitiligo Foundation can not provide a direct link to the full text or PDF version of the article.

To view articles from January through December 2009, please click here.

To view articles from January through December 2010, please click here.

Review Articles

MAY 2011

Kawakami T, Hashimoto T. Disease severity indexes and treatment evaluation criteria in vitiligo. Dermatol Res Pract. 2011.

Yaghoobi R, Omidian M, Bagherani N. Vitiligo: a review of the published work. J Dermatol. 2011 May;38(5):419-31.

Karelson M, Silm H, Salum T, Kõks S, Kingo K. Differences between familial and sporadic cases of vitiligo. J Eur Acad Dermatol Venereol. 2011 May 31.

Batchelor JM, Whitton ME, Pinart M, Leonardi-Bee J, Gonzalez U. Comment on: Vitiligo Treatment in Childhood: a State of the Art Review. By Tamesis MEB, Morelli JG: Pediatric Dermatology 2010;27(5):437-455. Pediatr Dermatol. 2011 May-Jun;28(3):354-5.

Pichaimuthu R, Ramaswamy P, Bikash K, Joseph R. A measurement of the stigma among vitiligo and psoriasis patients in India. Indian J Dermatol Venereol Leprol. 2011 May-Jun;77(3):300-6.


APRIL 2011

Nunes DH, Esser LM. Vitiligo epidemiological profile and the association with thyroid disease. An Bras Dermatol. 2011 Apr;86(2):241-8.


MARCH 2011

Nordlund JJ. Vitiligo: a review of some facts lesser known about depigmentation. Indian J Dermatol. 2011 Mar;56(2):180-9.

Matin R. Vitiligo in adults and children. Clin Evid (Online). 2011 Mar 28;2011.

Eleftheriadou V, Whitton ME, Gawkrodger DJ, Batchelor J, Corne J, Lamb B, Ersser S, Ravenscroft J, Thomas KS; on behalf of the vitiligo priority setting partnership. Future research into the treatment of vitiligo: where should our priorities lie? Results of the vitiligo priority setting partnership. Br J Dermatol. 2011 Mar;164(3):530-536.


FEBRUARY 2011

Boissy RE, Nordlund JJ. Vitiligo: current medical and scientific understanding. G Ital Dermatol Venereol. 2011 Feb;146(1):69-75.

Uncu S, Yaylı S, Bahadır S, Okten A, Alpay K. Relevance of autoimmune thyroiditis in children and adolescents with vitiligo. Int J Dermatol. 2011 Feb;50(2):175-9.

Westerhof W, Manini P, Napolitano A, d'Ischia M. The haptenation theory of vitiligo and melanoma rejection: a close-up. Exp Dermatol. 2011 Feb;20(2):92-6.

van Geel N, Speeckaert R, Taieb A, Picardo M, Böhm M, Gawkrodger DJ, Schallreuter K, Bennett DC, van der Veen W, Whitton M, Moretti S, Westerhof W, Ezzedine K, Gauthier Y; on behalf of the other VETF members. Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res. 2011 Feb 16.

Sandoval-Cruz M, García-Carrasco M, Sánchez-Porras R, Mendoza-Pinto C, Jiménez-Hernández M, Munguía-Realpozo P, Ruiz-Argüelles A. Immunopathogenesis of Vitiligo. Autoimmun Rev. 2011 Feb 17

Glassman SJ. Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond). 2011 Feb;120(3):99-120.


Return to top of page

Clinical Articles

JUNE 2011

Mouzakis JA, Liu S, Cohen G. Rapid response of facial vitiligo to 308nm excimer laser and topical calcipotriene. J Clin Aesthet Dermatol. 2011 Jun;4(6):41-4.

Linthorst Homan MW, Spuls PI, Nieuweboer-Krobotova L, de Korte J, Sprangers MA, Bos JD, Wolkerstorfer A, van der Veen JP. A randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients. J Eur Acad Dermatol Venereol. 2011 Jun 29.

van Geel N, Speeckaert R, Lambert J, Mollet I, De Keyser S, De Schepper S, Brochez L. Halo naevi with associated vitiligo-like depigmentations: pathogenetic hypothesis. J Eur Acad Dermatol Venereol. 2011 Jun 23.

Ismail WA, Al-Enzy SA, Alsurayei SA, Ismail AE. Vitiligo in a patient receiving infliximab for refractory ulcerative colitis. Arab J Gastroenterol. 2011 Jun;12(2):109-11.

Pan ZY, Yan F, Zhang ZH, Zhang QA, Xiang LH, Zheng ZZ. In vivo reflectance confocal microscopy for the differential diagnosis between vitiligo and nevus depigmentosus. Int J Dermatol. 2011 Jun;50(6):740-5.

Do JE, Shin JY, Kim DY, Hann SK, Oh SH. The effect of 308nm excimer laser on segmental vitiligo: a retrospective study of 80 patients with segmental vitiligo. Photodermatol Photoimmunol Photomed. 2011 Jun;27(3):147-51.


MAY 2011

Silverberg JI, Silverberg NB. Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color. J Drugs Dermatol. 2011 May 1;10(5):507-10.

Reddy IS, Swarnalatha G, Swain M. Asymptomatic papules and plaque in a patient with generalized vitiligo. Indian J Dermatol. 2011 May;56(3):341-2.

Zhang R, Zhu W. Genital vitiligo following use of imiquimod 5% cream. Indian J Dermatol. 2011 May;56(3):335-6.

Ezzedine K, Gauthier Y, Léauté-Labrèze C, Marquez S, Bouchtnei S, Jouary T, Taieb A. Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): A retrospective case series of 19 patients. J Am Acad Dermatol. 2011 May 24.

Karadag AS, Tutal E, Ertugrul DT. Insulin Resistance is Increased in Patients with Vitiligo. Acta Derm Venereol. 2011 May 20.

Hong WS, Hu DN, Qian GP, McCormick SA, Xu AE. Ratio of size of recipient and donor areas in treatment of vitiligo by autologous cultured melanocytes transplantation. Br J Dermatol. 2011 May 12.

Yao L, Li SS, Zhong SX, Song Y, Hu DN, Guo JW. Successful treatment of vitiligo on the axilla in a 5-year-old child by cultured-melanocyte transplantation. J Eur Acad Dermatol Venereol. 2011 May 5.

Pan H, Song W, Xu A. A case of vitiligo induced by tattooing eyebrow. Int J Dermatol. 2011 May;50(5):607-8.

Yamamoto Y, Tanioka M, Hayashino Y, Mishina H, Kato M, Fukuhara S, Utani A, Miyachi Y. Application of a two-question screening instrument to detect depressive symptoms in patients with vitiligo: a pilot study. J Am Acad Dermatol. 2011 May;64(5):e69-70.


APRIL 2011

Sharma P, Pai HS, Pai GS, Kuruvila M, Kolar R. Response to narrow-band UVB--vitiligo-melasma versus vitiligo: a comparative study. Am J Clin Dermatol. 2011 Apr 1;12(2):127-32.

Lee DY, Kim CR, Lee JH. Targeted phototherapy in combination with drug therapy for segmental vitiligo. Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):108-10.

Lee DY, Kim CR, Lee JH. Trichrome vitiligo in segmental type. Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):111-2.

Nordal E, Guleng G, Rönnevig J. Treatment of vitiligo with narrowband-UVB (TL01) combined with tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right/left double-blind comparative study. J Eur Acad Dermatol Venereol. 2011 Apr 6.

Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR. A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo. Br J Dermatol. 2011 Apr 1.


MARCH 2011

Krüger C, Smythe JW, Spencer JD, Hasse S, Panske A, Chiuchiarelli G, Schallreuter KU. Significant Immediate and Long-term Improvement in Quality of Life and Disease Coping in Patients with Vitiligo after Group Climatotherapy at the Dead Sea. Acta Derm VenereoL. 2011 Mar;91(2):152-9.

Narahari SR, Ryan TJ, Bose KS, Prasanna KS, Aggithaya GM. Integrating modern dermatology and Ayurveda in the treatment of vitiligo and lymphedema in India. Int J Dermatol. 2011 Mar;50(3):310-34.

Schallreuter KU, Panske A, Chiuchiarelli G. Ineffective topical treatment of vitiligo with Cucumis melo extracts. Int J Dermatol. 2011 Mar;50(3):374-5.

Lahita RG, Vernace MA. Vasculitis, vitiligo, thyroiditis, and altered hormone levels after anti-tumor necrosis factor therapy. J Rheumatol. 2011 Mar;38(3):579-80.

Szczurko O, Shear N, Taddio A, Boon H. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial. BMC Complement Altern Med. 2011 Mar 15;11:21.

Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M, Seneschal J, Boralevi F, Jouary T, Taieb A. Multivariate analysis of factors associated with early onset segmental and non-segmental Vitiligo: a prospective observational study of 213 patients. Br J Dermatol. 2011 Mar 17.

Kuchabal SD, Kuchabal DS. Alopecia Areata Associated with Localized Vitiligo. Case Rep Dermatol. 2010 Mar 27;2(1):27-31.

Rodríguez-García C, González-Hernández S, Pérez-Robayna N, Guimerá F, Fagundo E, Sánchez R. Repigmentation of vitiligo lesions in a child with celiac disease after a gluten-free diet. Pediatr Dermatol. 2011 Mar-Apr;28(2):209-10.

Jin Y, Xu A, Wang P, Song X, Liu X. Long-term follow-up and correlated factors of vitiligo following autologous epidermal transplantation. Cutis. 2011 Mar;87(3):137-41.

Yaghoobi R, Omidian M, Bagherani N. Original article title: "Comparison of therapeutic efficacy of topical corticosteroid and oral zinc sulfate-topical corticosteroid combination in the treatment of vitiligo patients: a clinical trial". BMC Dermatol. 2011 Mar 31;11:7.


FEBRUARY 2011

Barikbin B, Kavand S, Yousefi M, Hedayati M, Saeedi M. No differences in serum selenium levels and blood glutathione peroxidase activities in patients with vitiligo compared with healthy control subjects. J Am Acad Dermatol. 2011 Feb;64(2):444-5.

Silverberg JI, Silverberg NB. Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study. J Am Acad Dermatol. 2011 Feb;64(2):445-7.

Anbar Tel-D, Abdel-Raouf H, Awad SS, Ragaie MH. Perifollicular inflammatory infiltrate in vitiligo. Int J Dermatol. 2011 Feb;50(2):234-7.

Sahni K, Parsad D, Kanwar AJ, Mehta SD. Autologous noncultured melanocyte transplantation for stable vitiligo: can suspending autologous melanocytes in the patients' own serum improve repigmentation and patient satisfaction? Dermatol Surg. 2011 Feb;37(2):176-82.

Quezada N, Machado Filho CA, De La Sotta P, Uribe P. Melanocytes and keratinocytes transfer using sandpaper technique combined with dermabrasion for stable vitiligo. DerMatol Surg. 2011 Feb;37(2):192-8.

Tamler C, Duque-Estrada B, Oliveira PA, Avelleira JC. Tacrolimus 0,1% ointment in the treatment of vitiligo: a series of cases. An Bras Dermatol. 2011 Feb;86(1):169-172.

Berti S, Bellandi S, Bertelli A, Colucci R, Lotti T, Moretti S. Vitiligo in an Italian outpatient center: a clinical and serologic study of 204 patients in Tuscany. Am J Clin Dermatol. 2011 Feb 1;12(1):43-9.

Nigam PK, Patra PK, Khodiar PK, Gual J. A study of blood CD3+, CD4+, and CD8+ T cell levels and CD4+:CD8+ ratio in vitiligo patients. Indian J Dermatol Venereol Leprol. 2011 Jan-Feb;77(1):111.

Antelo DP, Filgueira AL, Cunha JM. Reduction of skin-homing cytotoxic T cells (CD8+ -CLA+) in patients with vitiligo. Photodermatol Photoimmunol Photomed. 2011 Feb;27(1):40-4.

Cho S, Zheng Z, Park YK, Roh MR. The 308-nm excimer laser: a promising device for the treatment of childhood vitiligo. Photodermatol Photoimmunol Photomed. 2011 Feb;27(1):24-9.


JANUARY 2011

Toossi P, Shahidi-Dadras M, Mahmoudi Rad M, Fesharaki R. Non-cultured melanocyte-keratinocyte transplantation for the treatment of vitiligo: a clinical trial in an Iranian population. J Eur Acad Dermatol Venereol. 2011 Jan 9.

Hu JJ, Xu AE, Wu XG, Sun XC, Luo XY. Small-sized lesions of childhood vitiligo treated by autologous epidermal grafting. J Dermatolog Treat. 2011 Jan 22.

Sun X, Qian G, Wu Y, Shen H, Wang T, Hu J, Guo B, Wu J, Xu A. Transplantation of autologous minigrafts for the treatment of stable vitiligo. J Dermatolog Treat. 2011 Jan 22.

Mohanty S, Kumar A, Dhawan J, Sreenivas V, Gupta S. Non-cultured extracted hair follicle outer root sheath cell suspension for transplantation in vitiligo. Br J Dermatol. 2011 Jan 28.


Return to top of page

Basic Science Articles

JUNE 2011

Tu CX, Jin WW, Lin M, Wang ZH, Man MQ. Levels of TGF-β(1) in serum and culture supernatants of CD4(+)CD25 (+) T cells from patients with non-segmental vitiligo. Arch Dermatol Res. 2011 Jun 5.

Esmaeili B, Rezaee SA, Layegh P, Tavakkol Afshari J, Dye P, Ghayoor Karimiani E, Kalalinia F, Rafatpanah H. Expression of IL-17 and COX2 Gene in Peripheral Blood Leukocytes of Vitiligo Patients. Iran J Allergy Asthma Immunol. 2011 Jun;10(2):81-9.

Kim JY, Do JE, Ahn KJ, Noh S, Jee HJ, Oh SH. Detection of melanocyte autoantigens reacting with autoantibodies in vitiligo patients by proteomics. J Dermatol Sci. 2011 Jun;62(3):202-4.

Elassiuty YE, Klarquist J, Speiser J, Yousef RM, El Refaee AA, Hunter NS, Shaker OG, Gundeti M, Nieuweboer-Krobotova L, Le Poole IC. Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo. Exp Dermatol. 2011 Jun;20(6):496-501.


MAY 2011

Zhou M, Guan C, Lin F, Xu W, Fu L, Hong W, Wan Y, Xu A. Immunodetection of the MCHR1 antibody in vitiligo patient sera. Int J Mol Med. 2011 May;27(5):725-9.

Deo SS, Bhagat AR, Shah RN. Genetic variations in nalp1 mRNA expressions in human vitiligo. Indian J Dermatol. 2011 May;56(3):266-71.

Guarneri F, Asmundo A, Sapienza D, Cannavò SP. Glutathione S-transferase M1/T1 gene polymorphisms and vitiligo in a Mediterranean population. Pigment Cell Melanoma Res. 2011 May 26.

Wu CS, Lan CC, Yu HS. Narrow-band UVB irradiation stimulates the migration and functional development of vitiligo-IgG antibodies-treated pigment cells. J Eur Acad Dermatol Venereol. 2011 May 4.


APRIL 2011

Bassiouny DA, Shaker O. Role of interleukin-17 in the pathogenesis of vitiligo. Clin Exp Dermatol. 2011 Apr;36(3):292-7.

Wang CQ, Cruz-Inigo AE, Fuentes-Duculan J, Moussai D, Gulati N, Sullivan-Whalen M, Gilleaudeau P, Cohen JA, Krueger JG. Th17 cells and activated dendritic cells are increased in vitiligo lesions. PLoS One. 2011 Apr 25;6(4).


MARCH 2011

Tippisetty S, Ishaq M, Komaravalli PL, Jahan P. Angiotensin converting enzyme (ACE) gene polymorphism in vitiligo: protective and predisposing effects of genotypes in disease susceptibility and progression. Eur J Dermatol. 2011 Mar 22.

Kim NH, Torchia D, Rouhani P, Roberts B, Romanelli P. Tumor necrosis factor-α in vitiligo: direct correlation between tissue levels and clinical parameters. Cutan Ocul Toxicol. 2011 Mar 9.

Elassiuty YE, Klarquist J, Speiser J, Yousef RM, El Refaee AA, Hunter NS, Shaker OG, Gundeti M, Nieuweboer-Krobotova L, Caroline Le Poole I. Heme oxygenase-1 expression protects melanocytes from stress-induced cell death: implications for vitiligo. Exp Dermatol. 2011 Mar 22.

Kumar R, Parsad D, Kanwar AJ, Kaul D. Altered levels of Ets-1 transcription factor and metalloproteinases in melanocytes from vitiligo patients. Br J Dermatol. 2011 Mar 24.

Lai LG, Xu AE. In vivo reflectance confocal microscopy imaging of vitiligo, nevus depigmentosus and nevus anemicus. Skin Res Technol. 2011 Mar 24.

Singh S, Singh U, Pandey SS. Increased level of serum Homocysteine in vitiligo. J Clin Lab Anal. 2011;25(2):110-2.

Zhou Q, Wang F, Zhang Y, Yang F, Wang Y, Sun S. Down-regulation of Prdx6 contributes to DNA vaccine induced vitiligo in mice. Mol Biosyst. 2011 Mar 1;7(3):809-16.

Douroudis K, Kingo K, Karelson M, Silm H, Reimann E, Traks T, Vasar E, Kõks S. The PRO2268 Gene as a Novel Susceptibility Locus for Vitiligo. Acta Derm Venereol. 2011 Mar;91(2):189-191.


FEBRUARY 2011

Czajkowski R. BRAF, HRAS, KRAS, NRAS and CDKN2A genes analysis in cultured melanocytes used for vitiligo treatment. Int J Dermatol. 2011 Feb;50(2):180-3.

van den Boorn JG, Picavet DI, van Swieten PF, van Veen HA, Konijnenberg D, van Veelen PA, van Capel T, Jong EC, Reits EA, Drijfhout JW, Bos JD, Melief CJ, Luiten RM. Skin-Depigmenting Agent Monobenzone Induces Potent T-Cell Autoimmunity toward Pigmented Cells by Tyrosinase Haptenation and Melanosome Autophagy. J Invest Dermatol. 2011 Feb 17.

Jin Y, Birlea SA, Fain PR, Gowan K, Riccardi SL, Holland PJ, Bennett DC, Herbstman DM, Wallace MR, McCormack WT, Kemp EH, Gawkrodger DJ, Weetman AP, Picardo M, Leone G, Taïeb A, Jouary T, Ezzedine K, van Geel N, Lambert J, Overbeck A, Spritz RA. Genome-Wide Analysis Identifies a Quantitative Trait Locus in the MHC Class II Region Associated with Generalized Vitiligo Age of Onset. J Invest Dermatol. 2011 Feb 17.


JANUARY 2011

Hu DY, Ren YQ, Zhu KJ, Lv YM, Cheng H, Zhang Z, Li Y, He SM, Tang J, Liu JL, Lin Y, Sun YY, Zuo XB, Chen G, Sun LD, Yang S, Zhang XJ. Comparisons of clinical features of HLA-DRB1*07 positive and negative vitiligo patients in Chinese Han population. J Eur Acad Dermatol Venereol. 2011 Jan 17.

Liu XM, Zhou Q, Xu SZ, Wakamatsu K, Lei TC. Maintenance of immune hyporesponsiveness to melanosomal proteins by DHICA-mediated antioxidation: Possible implications for autoimmune vitiligo. Free Radic Biol Med. 2011 Jan 21.

Kumar R, Parsad D, Kanwar AJ. Role of apoptosis and melanocytorrhagy: a comparative study of melanocyte adhesion in stable and unstable vitiligo. Br J Dermatol. 2011 Jan;164(1):187-91.

Kemp EH, Emhemad S, Akhtar S, Watson PF, Gawkrodger DJ, Weetman P. Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo. Exp Dermatol. 2011 Jan;20(1):35-40.


Return to top of page